Alessandro Levis

机构：California Institute of Technology · ORCID：0000-0001-7307-632X

发表论文 235 篇 · 总被引 13848 次 · h-index 50

代表论文

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016 · The Lancet Haematology · 被引 613)
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial (2017 · The Lancet Haematology · 被引 390)
Time-dependent changes in mortality and transformation risk in MDS (2016 · Blood · 被引 180)
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi (2014 · Annals of Oncology · 被引 173)
Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study (2016 · Journal of Clinical Oncology · 被引 149)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) (2015 · Leukemia · 被引 137)